Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA).

PHASE4RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 6, 2024

Primary Completion Date

March 10, 2026

Study Completion Date

June 1, 2026

Conditions
Brain FogCognitive Health
Interventions
DIETARY_SUPPLEMENT

Monoglyceride Eicosapentaenoic acid (omega-3)

515 mg MAG-EPA + 33 mg MAG-DHA per capsule x 3 capsules daily: 1.5g/day (MAG-EPA). Subjects will be treated over a period of 56 days (or 112 days in phase 2) followed by a wash-out period of 28 days.

OTHER

Sunflower Oil

698 mg sunflower oil per capsule x 3 capsules: 2.0g/d sunflower oil (Placebo) Subjects will be treated over a period of 112 days followed by a wash-out period of 28 days.

Trial Locations (2)

G0C 1Y0

RECRUITING

Institut de recherche clinique du littoral (IRCL), Maria

G0K 1P0

NOT_YET_RECRUITING

Institut de recherche clinique du littoral (IRCL), Rimouski

All Listed Sponsors
collaborator

Institut de recherche clinique du littoral (IRCL)

UNKNOWN

lead

Samuel Fortin

INDUSTRY

NCT06695910 - Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA). | Biotech Hunter | Biotech Hunter